Center for U.S. Policy
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
Category

Issues

FDA Approves Weekly Injectable Buprenorphine

FDA Approves Weekly Injectable Buprenorphine

News May 24, 2023
FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning

FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning

News May 23, 2023
Good Intentions Alone Won’t Reduce Drug Poisonings

Good Intentions Alone Won’t Reduce Drug Poisonings

News May 16, 2023
Pharmacy-Based Dispensing of Methadone for OUD: How it Happens

Pharmacy-Based Dispensing of Methadone for OUD: How it Happens

CUSP Research May 16, 2023
Pharmacy-Based Dispensing of Methadone for OUD: Permissibility & Feasibility

Pharmacy-Based Dispensing of Methadone for OUD: Permissibility & Feasibility

CUSP Research May 16, 2023
Woman speaking with health care provider

CUSP FDA Citizen Petition to Protect Patients

CUSP Research April 28, 2023
DEA Stonewalls FOIA Request

DEA Stonewalls FOIA Request

CUSP Research, News April 7, 2023
Webinar “Change Is Law: A Federal Drug Policy Update”

Webinar “Change Is Law: A Federal Drug Policy Update”

CUSP Research March 29, 2023
Model Act Promotes SUD Treatment in EDs

Model Act Promotes SUD Treatment in EDs

News March 22, 2023
FOIA: CUSP’s Second Overdue Response Notice

FOIA: CUSP’s Second Overdue Response Notice

CUSP Research March 15, 2023
DEA Proposes Rules for Permanent Telemedicine Flexibilities

DEA Proposes Rules for Permanent Telemedicine Flexibilities

News March 1, 2023
Millennium Health Report on Polysubstance Use in 2022

Millennium Health Report on Polysubstance Use in 2022

News February 28, 2023
Loading...
« Previous
Print page

© 2025 Center for U.S. Policy. All Rights Reserved.